Related Experiment Video
Updated: May 16, 2025

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.1K
Coupling deep phenotypic quantification with next-generation phenotyping for 192 individuals with germline
Emily E Lubin1, Elizabeth M Gonzalez1, Annabel K Sangree1
1University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
HGG Advances
|April 17, 2025
Summary
Mendelian histonopathies, rare neurodevelopmental disorders, were investigated in 192 individuals. This study identified new gene variants and highlighted the need for longitudinal evaluation and cancer surveillance in affected individuals.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
- Rare Diseases
Background:
- Mendelian histonopathies are rare neurodevelopmental disorders (NDDs) stemming from germline variants in histone-encoding genes.
- Previous studies have focused on specific histonopathy syndromes, limiting a comprehensive understanding of the broader disease spectrum.
Purpose of the Study:
- To conduct an expansive pan-histonopathy interrogation, analyzing data from 192 affected individuals.
- To identify novel gene variants associated with histonopathies and explore phenotypic patterns, including craniofacial features.
- To develop an updated clinical survey to improve the identification and understanding of histonopathy phenotypes and associated risks, such as cancer.
Main Methods:
- Analysis of data from 192 individuals with histonopathies, including published and unpublished cases.
- Integration of clinician-reported phenotypic data with computational phenotyping of 2D facial photographs.
- Development and application of a standardized clinical survey for data collection.
Main Results:
- Identification of variants in genes not previously associated with disease (e.g., HIST1H2AL, H2AFZ, HIST1H3D, HIST3H3).
- Analysis revealed data gaps that currently confound the identification of distinct phenotypic patterns.
- The second known individual with a germline histonopathy and cancer diagnosis was identified; overall cancer incidence is 1%.
Conclusions:
- Histonopathy phenotypes evolve across the lifespan, requiring longitudinal assessment.
- Each identified individual significantly contributes to understanding these syndromes and improving patient care.
- Further translational research is crucial to clarify cancer predisposition in individuals with germline histonopathies.

